EMA Withdrawn: Parareg (cinacalcet) — Dompé Biotec S.p.A.

View source ↗

Summary

EMA withdrawn status for Parareg (cinacalcet) by Dompé Biotec S.p.A., with therapeutic areas including hypercalcemia, parathyroid neoplasms, and hyperparathyroi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercalcemia
• Hyperparathyroidism
• Parathyroid Neoplasms

Drugs mentioned

• Parareg (cinacalcet)

Snippet

Status: Withdrawn. Therapeutic area: Hypercalcemia;Parathyroid Neoplasms;Hyperparathyroidism. MAH: Dompé Biotec S.p.A.. Decision date: 29/10/2008